过去一年中添加的文章，按日期排序
[HTML][HTML] COVID-19-Associated Sepsis: Potential Role of Phytochemicals as Functional Foods and Nutraceuticals
B de Souza Goncalves, D Sangani, A Nayyar… - International Journal of …, 2024 - mdpi.com
2 天前 - … to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection leads
to … site of SARS-CoV-2 Mpro, and it can thus be a potential therapeutic against COVID-19 [202…
to … site of SARS-CoV-2 Mpro, and it can thus be a potential therapeutic against COVID-19 [202…
Engineering a NanoBiT biosensor for detecting angiotensin-converting enzyme-2 (hACE2) interaction with SARS-CoV-2 spike protein and screening the inhibitors to …
CH Lin, XR Yang, MW Lin, HJ Chang, CH Lee… - Biosensors and …, 2024 - Elsevier
2 天前 - … Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is …
and is a primary target for therapeutic intervention against COVID-19. However, it is difficult to …
and is a primary target for therapeutic intervention against COVID-19. However, it is difficult to …
[HTML][HTML] Computational Modeling and Inhibition of SARS-COV-2 Papain-like Protease Enzyme: A Potential Therapeutic Approach for COVID-19
2 天前 - … The structural similarities shared between SARS-CoV and SARS-CoV-2 PLpro
present … therapeutic strategies against SARS-CoV- 2. Since the emergence of COVID-19 in late …
present … therapeutic strategies against SARS-CoV- 2. Since the emergence of COVID-19 in late …
Using virtual patient cohorts to uncover immune response differences in cancer and immunosuppressed COVID-19 patients
S Gazeau, X Deng, E Brunet-Ratnasingham… - bioRxiv, 2024 - biorxiv.org
2 天前 - … with SARS-CoV-2 and to investigate drivers of COVID-19 … immune response during
COVID-19 and generated virtual … suggest the consideration of inhibitory therapies, as GM-…
COVID-19 and generated virtual … suggest the consideration of inhibitory therapies, as GM-…
[HTML][HTML] Valproic acid use is associated with diminished risk of contracting COVID-19, and diminished disease severity: Epidemiologic and in vitro analysis reveal …
A Watson, P Shah, D Lee, S Liang, G Joshi, E Metitiri… - PloS one, 2024 - journals.plos.org
3 天前 - … coronavirus antiviral therapeutics, many FDA-approved drugs were assessed for
potential repurposing against COVID-19… as background from input SARS-CoV-2. Spent media …
potential repurposing against COVID-19… as background from input SARS-CoV-2. Spent media …
[HTML][HTML] Investigation of the relationship between COVID-19 and pancreatic cancer using bioinformatics and systems biology approaches
C Fang, H Sun, J Wen, X Wu, Q Wu, D Zhai - Medicine, 2024 - journals.lww.com
3 天前 - … therapeutic agents against both COVID-19 and PC. … Coronavirus disease 2019
(COVID-19) is a respiratory … severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [ 1 …
(COVID-19) is a respiratory … severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). [ 1 …
[HTML][HTML] Cardiovascular disease and covid-19: A systematic review
BA Krishna, M Metaxaki, N Sithole, P Landín… - IJC Heart & …, 2024 - Elsevier
3 天前 - … Long COVID can affect cardiovascular health. Microclotting induced by SARS-CoV-2
infection could be a therapeutic target for some aspects of Long Covid. …
infection could be a therapeutic target for some aspects of Long Covid. …
Progress in Research on Inhibitors Targeting SARS-CoV-2 Main Protease (Mpro)
Y Yang, YD Luo, CB Zhang, Y Xiang, XY Bai… - ACS …, 2024 - ACS Publications
3 天前 - … As of March 21, 2023, RAY1216 has been authorized as a COVID-19 therapeutic,
with Phase III trials indicating its efficacy in treating mild to moderate SARS-CoV-2 infections, …
with Phase III trials indicating its efficacy in treating mild to moderate SARS-CoV-2 infections, …
An overview of the development of pharmacotherapeutics targeting SARS-CoV-2
T Lucaj, I Hay, A Samarbakhsh, M Bedi, AK Iyer… - Drug Discovery …, 2024 - Elsevier
3 天前 - … launched subsequent to the identification of SARS-CoV-2, COVID-19’s rapid
transmission and its … Developing therapies to target SARS-CoV-2 relies on a comprehensive …
transmission and its … Developing therapies to target SARS-CoV-2 relies on a comprehensive …
[PDF][PDF] Genomic analysis of Staphylococcus aureus isolates from bacteremia reveals genetic features associated with the COVID-19 pandemic
M Osuna, P Pedrosa, OG Erill, OQ Pich - researchgate.net
3 天前 - … use in COVID-19 accessory therapy and elevated fibrinogen levels in SARS-CoV-2
infection. These findings highlight S. aureus adaptation to COVID-19 selective pressures …
infection. These findings highlight S. aureus adaptation to COVID-19 selective pressures …